文献速递临床试验与 GCP

术前免疫营养对结肠癌手术结局影响的随机对照试验研究方案

Effect of preoperative immunonutrition on outcomes of colon cancer surgery: study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2020-07-08

本研究为随机对照试验方案,拟纳入原发性结肠癌患者,按1:1随机分为术前免疫营养加正常饮食组与单纯正常饮食组,实验组术前7天口服含精氨酸和ω-3脂肪酸的补充剂400 mL/天。主要终点为感染性并发症发生率,假设实验组为13%、对照组为30%,计算样本量为176例(每组88例)。

要点

  • 术前免疫营养能否降低结肠癌手术感染并发症仍存争议。
  • 试验计划入组176例结肠癌患者,1:1随机分组。
  • 主要终点为感染性并发症发生率,次要终点包括术后并发症率、体重变化、住院时长和粪便微生物组特征。

核心结论

  • 该试验旨在评估术前免疫营养对结肠癌手术结局的影响,以期为临床提供证据。

研究设计与样本

  • 随机对照试验方案,计划纳入原发性结肠癌患者,按1:1随机分为实验组和对照组,样本量176例(每组88例)。
  • 实验组术前7天口服补充精氨酸和ω-3脂肪酸400 mL/天,对照组仅正常饮食。

关键数值与推荐

  • 主要终点为感染性并发症发生率,假设实验组为13%、对照组为30%。
  • 设定双侧α=0.05、检验效能0.8,计算样本量为176例(每组88例)。
  • 次要终点包括术后并发症率、体重变化、住院时长和粪便微生物组特征。

局限性

  • 既往研究存在样本量小和潜在发表偏倚的局限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Current guidelines recommend the prescription of immune-enriched oral nutritional supplements for malnourished patients before major gastrointestinal surgery. However, the benefit of preoperative immunonutrition is still controversial. This randomized controlled trial aims to evaluate the effect of preoperative immunonutrition on the outcomes of surgery for colon cancer. METHODS/DESIGN: Patients with primary colon cancer will be included as study participants after screening. They will be randomly assigned (in a ratio of 1:1) to receive preoperative immunonutrition added to the normal diet (experimental arm) or consume normal diet alone (control arm). Patients in the experimental arm will receive oral supplementation (400 mL/day) with arginine and ω-3 fatty acids for 7 days before elective surgery. The primary endpoint is the rate of infectious complications, while the secondary endpoints are postoperative complication rate, change in body weight, length of hospital stay, and nature of fecal microbiome. The authors hypothesize that the rate of infectious complications would be 13% in the experimental arm and 30% in the control arm. With a two-sided alpha of 0.05 and a power of 0.8, the sample size is calculated as 176 patients (88 per arm). DISCUSSION: Although there have been many studies demonstrating significant benefits of preoperative immunonutrition, these were limited by a small sample size and potential publication bias. Despite the recommendation of immunonutrition before surgery in nutritional guidelines, its role in reduction of rate of infectious complications is still controversial. This trial is expected to provide evidence for the benefits of administration of preoperative immunonutrition in patients with colon cancer. TRIAL REGISTRATION: Clinical Research Information Service KCT0003770 . Registered on 15 April 2019.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Lee SY, Yeom SS, Kim CH, et al. Effect of preoperative immunonutrition on outcomes of colon cancer surgery: study protocol for a randomized controlled trial. Trials. 2020. PMID: 32641081. doi:10.1186/s13063-020-04544-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。